| Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008 (NCT04770194) | Shin Poong Pharmaceutical Co. Ltd. | 2019-10-01 |
| A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (NCT04124094) | Respirent Pharmaceuticals Co Ltd. | 2019-10-01 |
| Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations (NCT03599466) | Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited | 2019-10-01 |
| Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae. (NCT04165551) | Biosearch S.A. | 2019-10-01 |
| Clinical Study New Gel for Xerostomia (NCT04184908) | Universidad de Murcia | 2019-10-01 |
| RhEGF Incorporated in An Absorbable Collagen Membrane for The Management Of Gingival Recession Defects (NCT04375618) | SVS Institute of Dental Sciences | 2019-10-01 |
| A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab (NCT04112498) | Bristol-Myers Squibb | 2019-10-01 |
| A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327 (NCT04069143) | Bristol-Myers Squibb | 2019-10-01 |
| OTO-413 in Subjects With Speech-in-Noise Hearing Impairment (NCT04129775) | Otonomy, Inc. | 2019-10-01 |
| Implication of Fluid Strategies Upon Hepatic Outcome in Hepatobiliary Surgery (NCT03923816) | Assiut University | 2019-10-01 |
| Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis (NCT04062331) | Maimónides Biomedical Research Institute of Córdoba | 2019-10-01 |
| Biological Effects of Quercetin in COPD (NCT03989271) | Temple University | 2019-10-01 |
| Cannabidiol for Alcohol Use Disorder (NCT03904849) | Medical University of South Carolina | 2019-10-01 |
| Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer (NCT03994107) | Peking Union Medical College | 2019-10-01 |
| Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate (NCT03749733) | Grünenthal GmbH | 2019-10-01 |
| Chemoradiotherapy in Unresectable Esophageal Cancer (NCT04278287) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-10-01 |
| The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants (NCT04113668) | Bristol-Myers Squibb | 2019-10-01 |
| Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial (NCT04091698) | Cairo University | 2019-10-01 |
| Ocrelizumab for Psychosis by Autoimmunity (NCT03971487) | The Methodist Hospital Research Institute | 2019-10-01 |
| Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study (NCT03748303) | University of Arizona | 2019-10-01 |
| Stem Cell Therapy in Non-IschEmic Non-treatable Dilated CardiomyopathiEs II: a Pilot Study (NCT03797092) | JKastrup | 2019-10-01 |
| A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets (NCT04097600) | Novo Nordisk A/S | 2019-09-30 |
| Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans (NCT04032301) | University of Minnesota | 2019-09-30 |
| Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas (NCT03631953) | Assistance Publique Hopitaux De Marseille | 2019-09-30 |
| Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers (NCT03761914) | Sellas Life Sciences Group | 2019-09-30 |
| A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881 (NCT04128787) | Agios Pharmaceuticals, Inc. | 2019-09-30 |
| A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma (NCT04082936) | IGM Biosciences, Inc. | 2019-09-30 |
| A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults (NCT04116632) | Bristol-Myers Squibb | 2019-09-30 |
| Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants (NCT04095286) | GlaxoSmithKline | 2019-09-30 |
| A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) (NCT03989414) | Celgene | 2019-09-30 |
| Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients (NCT04102852) | San Giovanni Addolorata Hospital | 2019-09-30 |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas (NCT03670069) | Fred Hutchinson Cancer Center | 2019-09-30 |
| Bright Light Therapy in the Treatment of Non-seasonal Bipolar Depression (NCT03396744) | Assistance Publique - Hôpitaux de Paris | 2019-09-30 |
| Response to Influenza Vaccine During Pregnancy (NCT03888989) | Stanford University | 2019-09-30 |
| A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants (NCT04075409) | UCB Biopharma S.P.R.L. | 2019-09-30 |
| A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients (NCT04042324) | Rockwell Medical Technologies, Inc. | 2019-09-30 |
| Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug (NCT04095273) | Bayer | 2019-09-30 |
| Trial of DFP-14927 in Advanced Solid Tumors (NCT03943004) | Delta-Fly Pharma, Inc. | 2019-09-30 |
| A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma (NCT03970616) | AVEO Pharmaceuticals, Inc. | 2019-09-30 |
| PCSK9 Inhibitor Treatment for Patients With SPG5 (NCT04101643) | First Affiliated Hospital of Fujian Medical University | 2019-09-29 |
| A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy (NCT04316624) | Institute of Hematology & Blood Diseases Hospital, China | 2019-09-29 |
| Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites (NCT04051112) | Sichuan Clover Biopharmaceuticals, Inc. | 2019-09-28 |
| Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma (NCT04052334) | H. Lee Moffitt Cancer Center and Research Institute | 2019-09-27 |
| A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide (NCT04091373) | MedImmune LLC | 2019-09-27 |
| VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine (NCT04130282) | University of Oxford | 2019-09-27 |
| A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients (NCT03950414) | University of Wisconsin, Madison | 2019-09-27 |
| Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) (NCT03740178) | Merck Sharp & Dohme LLC | 2019-09-27 |
| Evaluation of AP-002 in Patients With Solid Tumors (NCT04143789) | Altum Pharmaceuticals INC | 2019-09-27 |
| Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer (NCT03936465) | Dana-Farber Cancer Institute | 2019-09-27 |
| Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease (NCT04149860) | H. Lundbeck A/S | 2019-09-27 |
| KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor (NCT04040699) | Peking University | 2019-09-26 |
| KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer (NCT03915405) | Kyowa Kirin, Inc. | 2019-09-26 |
| First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM) (NCT04083534) | Regeneron Pharmaceuticals | 2019-09-26 |
| Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers (NCT03968406) | M.D. Anderson Cancer Center | 2019-09-26 |
| Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients (NCT04097821) | Novartis Pharmaceuticals | 2019-09-26 |
| Single Ascending Dose Study in Participants With LCA10 (NCT03872479) | Editas Medicine, Inc. | 2019-09-26 |
| Targeting Orexin to Treat Nicotine Dependence (NCT03999099) | Mclean Hospital | 2019-09-26 |
| A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC (NCT04108247) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-26 |
| Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness (NCT04137432) | University Hospital, Bonn | 2019-09-26 |
| A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers (NCT04104997) | GL Pharm Tech Corporation | 2019-09-26 |
| A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors (NCT04045496) | Jacobio Pharmaceuticals Co., Ltd. | 2019-09-26 |
| Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer (NCT02964507) | GlaxoSmithKline | 2019-09-26 |
| Use of Tilapia Skin for Palate Repair and Protection After Graft Removal (NCT04168125) | University of Sao Paulo | 2019-09-26 |
| Metabolic Effects of Melatonin Treatment (NCT03859934) | University of Aarhus | 2019-09-26 |
| First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone (NCT04075721) | EMD Serono Research & Development Institute, Inc. | 2019-09-26 |
| Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine (NCT04179474) | Allergan | 2019-09-26 |
| Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours (NCT03326388) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2019-09-26 |
| A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants (NCT04092595) | Pfizer | 2019-09-26 |
| An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma (NCT03779113) | Hutchmed | 2019-09-26 |
| Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer (NCT04121676) | Agenus Inc. | 2019-09-26 |
| A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001) (NCT04055454) | Themis Bioscience GmbH | 2019-09-26 |
| Evaluation of Safety and Tolerability of Libella Gene Therapy for Critical Limb Ischemia: AAV- hTERT (NCT04110964) | Libella Gene Therapeutics | 2019-09-26 |
| An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) (NCT04113616) | Kartos Therapeutics, Inc. | 2019-09-25 |
| Safety and Tolerability of BDB-001 Injection in Healthy Subjects (NCT05360927) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2019-09-25 |
| First-In-Human Study of Apramycin (NCT04105205) | Juvabis AG | 2019-09-25 |
| INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma (NCT03837509) | Incyte Corporation | 2019-09-25 |
| Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2) (NCT03915184) | CARsgen Therapeutics Co., Ltd. | 2019-09-25 |
| Functional Endoscopic Sinus Surgery Study (NCT03970655) | University of Florida | 2019-09-25 |
| Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma (NCT03803774) | National Cancer Institute (NCI) | 2019-09-25 |
| A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults (NCT04090658) | GlaxoSmithKline | 2019-09-25 |
| Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer (NCT03900884) | Peter MacCallum Cancer Centre, Australia | 2019-09-25 |
| A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors (NCT04135261) | Harbour BioMed US, Inc. | 2019-09-24 |
| A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants (NCT04096157) | Astellas Pharma Global Development, Inc. | 2019-09-24 |
| Glucagon Regulation of Glucose Metabolism (NCT04347252) | David D'Alessio, M.D. | 2019-09-24 |
| Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease (NCT04617860) | Wave Life Sciences USA, Inc. | 2019-09-24 |
| Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia (NCT04072237) | Catalyst Biosciences | 2019-09-24 |
| Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia (NCT03991884) | University of Washington | 2019-09-24 |
| Autologous Human Schwann Cells in Peripheral Nerve Repair (NCT03999424) | W. Dalton Dietrich | 2019-09-24 |
| A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants (NCT04090047) | Pfizer | 2019-09-24 |
| PDE6A Gene Therapy for Retinitis Pigmentosa (NCT04611503) | STZ eyetrial | 2019-09-24 |
| Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers (NCT04238663) | mAbxience Research S.L. | 2019-09-24 |
| A Pilot Study of Terazosin for Parkinson's Disease (NCT03905811) | Jordan Schultz | 2019-09-24 |
| THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis (NCT04199468) | Yale University | 2019-09-24 |
| Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects (NCT04024332) | Idorsia Pharmaceuticals Ltd. | 2019-09-24 |
| Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep (NCT04093271) | LifeSeasons Inc. | 2019-09-24 |
| Effect of Octreotide on Saliva (NCT05340192) | Duke University | 2019-09-24 |
| Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors (NCT04087018) | Arcus Biosciences, Inc. | 2019-09-24 |
| Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman (NCT04197349) | H. Lundbeck A/S | 2019-09-24 |
| Safety and Efficacy Study of IMSA101 in Refractory Malignancies (NCT04020185) | ImmuneSensor Therapeutics Inc. | 2019-09-23 |
| Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects (NCT04480697) | Hepagene (Shanghai) Co., Ltd. | 2019-09-23 |